Curricular Components for Rheumatology EPA

Similar documents
Curricular Components for Cardiology EPA

Curricular Components for Infectious Diseases EPA

Entrustable Professional Activity

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Entrustable Professional Activity

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.

Curricular Components for Hematology/Oncology EPA

Entrustable Professional Activity

Curricular Components for General Pediatrics EPA EPA Title Assess and manage patients with common behavior/mental health problems

FAQ Identifying and enrolling participants

Entrustable Professional Activity

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition

Curricular Components for Child Sexual Abuse EPA

Index. Note: Page numbers of article titles are in boldface type.

: Provide cardiovascular preventive counseling to parents and patients with specific cardiac diseases about:

VASCULITIS AND VASCULOPATHY

M3 Pediatric Clerkship

Rheumatology Residency Rotation University of Colorado Health Sciences Center

Lahey Clinic Internal Medicine Residency Program: Curriculum for Rheumatology

LAC-USC Cardiology Consult Service

PAEDIATRIC VASCULITIS

CENTRAL NERVOUS SYSTEM VASCULITIS

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Nephrology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Visiting Professional Programme: Rheumatology

GRANULOMATOSIS WITH POLYANGIITIS

Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective

CONTENT OUTLINE. Pediatric Rheumatology

KAWASAKI DISEASE. What is Kawasaki disease? Causes

Financial Report. Moving Together

SPARN Guideline for a paediatric rheumatology network service February Review date March 2018

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Personal data Curriculum Vitae

Atlas of the Vasculitic Syndromes

Curriculum Vitae Last Update: 8/6/2018

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

*GERIATRIC FELLOWSHIP COMPETENCY CHECKLIST EDUCATIONAL GOALS:

Rheumatology Educational Goals & Objectives

Best Practices in the Diagnosis and Management of OA

Cardiology Competency Based Goals and Objectives

Geriatric Medicine I) OBJECTIVES

Familial Mediterranean Fever

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Small Vessel Vasculitis

PGALS: Approach to Child with Arthritis. Prof Chris Scott Paediatric Rheumatology

How Is Lupus Diagnosed?

Committee Approval Date: May 9, 2014 Next Review Date: May 2015

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

2. Description of the activity

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

DEPARTMENT OF RHEUMATOLOGY

Cerebrovascular Disease

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

UCSD DEPARTMENT OF ANESTHESIOLOGY

EPUB / LIST AUTOIMMUNE DISEASES DOCUMENT

Systemic Autoimmune Rheumatic Disease Fellowship, McGill University

EVALUATION OF USE OF BELIMUMAB IN CLINICAL PRACTICE SETTINGS PATIENT CASE RECORD FORM PHASE II, MONTH PATIENT FOLLOW-UP

REFERRAL GUIDELINES: RHEUMATOLOGY

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

Clinical Commissioning Policy Proposition:

University of Nebraska Medical Center Rheumatology Fellowship. Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun R/S R/S R/S R/S

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Geriatric Medicine Rotation. Contact Person: Dr. Lotika Pandit

Orthopedics. 1. GOAL: Understand the pediatrician's role in preventing and screening for

JC Sunnybrook HEALTH SCIENCES CENTRE

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Clinical Commissioning Policy Statement: Rituximab For Systemic Lupus Erythematosus (SLE) December Reference : NHSCB/A3C/1b

Scope of Practice Specialist Physicians in Immunology and Allergy in Australia

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Contents. Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv. Speakers Abstracts

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

A number of factors point to the likelihood of a person with RA developing RV:

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Renflexis (infliximab-abda)

Milestone Compatible Neurology Faculty of Resident Evaluation Template

Endocrine Evaluation

Employment of a needs assessment survey to shape a novel web-based pediatric rheumatology curriculum for primary care providers

IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists

Vasculitis in primary connective tissue diseases

Personality Disorder Integrated Care Pathway (PD ICP) 12: Inpatient Care

Lupus and Friends Perspectives on common syndromes and Primary care responses

Summary of Major Differences Between Guide2 and Guide3

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Adult Neurology Residency Training Program McGill University Rotation Specific Objectives. EEG/Epilepsy Rotation

SCOPE OF PRACTICE PGY-4 PGY-5

JuvenileIdiopathicArthritis. Dr Johan Siebert

Diagnostic Procedures for Vasculitis

IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

ENDOCRINE ASSESSMENT TOOLS. NAS TASK FORCE June 2014 NAS TASK FORCE

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

LRI Children s Hospital

TAKAYASU S ARTERITIS. Second-stage symptoms include:

Clinical Commissioning Policy Proposition: Rituximab for cytopaenia complicating primary immunodeficiency

Educational Goals & Objectives

Transcription:

Curricular Components for Rheumatology EPA 1. EPA Title Manage patients with acute or chronic complex multi-system rheumatic disease in an ambulatory, emergency, or inpatient setting. 2. Description of the activity Children with complex multi-system rheumatic disease constitute a challenging but critical activity for the rheumatologist. This core EPA for the rheumatologists requires the mastery of providing efficient and effective care to a large number of patients with suspected and confirmed autoimmune and auto inflammatory disease. The focal components of this professional activity build upon those of managing both the clinic patient with more common rheumatic diseases as well as the more acutely ill hospitalized patient. The specific functions which define this EPA include: Developing knowledge of rheumatic autoimmune diseases, auto-inflammatory diseases, and associated musculoskeletal conditions specific to children, adolescents and young adults. Performing general and specialized history and physical examinations (e.g. rheumatologic review of systems and musculoskeletal examination) in order to care for patients with chronic complex multi-system rheumatic disease Developing sound clinical reasoning that drives the creation of an appropriate differential diagnosis and evaluation Applying guidelines, evidence-based literature, and/or consensus treatment plans to the care of patients Developing and documenting a management plan that addresses the primary problem, all comorbidities, as well as cost considerations Coordinating care in different health care settings (e.g. ER, hospital) and with an inter-disciplinary health care team Placing the patient at the center of all management decisions Demonstrating the ability to manage uncertainty (one s own as well as that of the patient and family). 3. Judicious mapping to _X_ Patient Care _X_ Medical Knowledge _X_ Practice-based Learning and Improvement

domains of competence 4. Competencies within each domain critical to entrustment decisions _X_ Interpersonal & Communication Skills Professionalism _X_ Systems-based Practice _X_ Personal & Professional Development PC 1: Gathering information PC 5: Performing complete physical exams PC 7: Developing management plans MK 1: Demonstrating knowledge PBLI 6: Practicing EBM ICS 1: Communicating with patients/families ICS 3: Communicating with health professionals SBP 2: Coordinating care PPD 8: Dealing with uncertainty 5. Curricular Components that support the functions of the EPA (knowledge, skills and attitudes needed to execute this EPA safely): Rationale: Pediatric rheumatologists must be able to diagnose and manage patients with acute or chronic complex multi-system rheumatic disease in a variety of settings including outpatient clinic, the emergency room and in the hospital. All of these settings will require coordination of care with a multidisciplinary health care team. Scope of Practice: Care is provided in the ambulatory and inpatients setting. The pediatric rheumatologists also serve as a resource for telephone, electronic, and remote consultation, and care is occasionally supervised in-home or at remote sites. The patient population includes all patients with rheumatic, inflammatory, and autoimmune diseases, and associated musculoskeletal conditions followed regularly in the pediatric rheumatology clinic and patients evaluated as requested consultations. Patients will range in age from newborns to young adults. This document is intended to address the scope of knowledge and skills of the pediatric rheumatologist, with the understanding that the pediatric rheumatologist will often need to create and lead multidisciplinary teams and require evaluation and management input from other health care professionals, and participate in quality improvement. Curricular components that support the functions of the EPA: Developing knowledge of rheumatic autoimmune diseases, auto-inflammatory diseases, and associated musculoskeletal conditions specific to children, adolescents and young adults. Such diseases include but are not limited to: Juvenile Idiopathic Arthritis (all subtypes) Inflammatory Eye Disease Idiopathic Inflammatory Myositis Systemic Vasculitis (Henoch-Scholein Purpura, Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, Polyarteritis nodosa, Kawasaki disease, Takayasu arteritis, Behçet disease, central nervous system vasculitis)

Systemic Lupus Erythematosus and Related Disorders Scleroderma, local and systemic and Related Disorders Autoinflammatory diseases Primary immunodeficiencies and other disorders associated with inflammatory and autoimmune manifestations Arthritis related to infection and associated conditions Non-inflammatory musculoskeletal conditions Performing general and specialized history and physical examinations (e.g. rheumatologic review of systems and musculoskeletal examination) in order to care for patients with chronic complex multi-system rheumatic disease Obtains a thorough clinical history, relevant review of systems, and assess functional status of children, adolescents, and young adults with rheumatic and musculoskeletal disease symptoms. Assimilates, organizes, and succinctly summarizes all pertinent previously obtained medical information from the Emergency Department, Primary Care Physician, outside hospital, and/or other subspecialists. Performs and interprets a complete general physical examination Performs and accurately interprets the examination of all joints, periarticular structures, peripheral nerves and muscles. Identifies extra-articular findings associated with rheumatic and autoimmune diseases, and inflammatory and associated musculoskeletal conditions. Identifies ocular manifestations and complications of rheumatologic and musculoskeletal disease in children, adolescents and young adults. Frequently reassesses to assure correct diagnosis and/or response to therapy. Developing sound clinical reasoning that drives the creation of an appropriate differential diagnosis and evaluation Develops a differential diagnosis in patients presenting with signs and symptoms of potential rheumatologic diseases and outlines further testing necessary to establish the correct diagnosis. Explains the indications for and costs of laboratory tests, imaging studies, and procedures to establish a diagnosis of rheumatic and autoimmune diseases, and inflammatory and associated musculoskeletal conditions. Accurately interprets the results of laboratory tests, imaging studies, pathology, and other studies. Reassesses to assure appropriate diagnosis. Applying guidelines, evidence-based literature, and/or consensus treatment plans to the care of patients Develops a clinical question using the PICO format. Searches the literature for evidence focusing on the highest grade evidence available. Interprets the evidence in light of its grade.

Applies the evidence to the care of the patient given the particular context for that patient. Adheres to evidence-based practice and/or commonly accepted guidelines for comorbidity screening and toxicity monitoring. Developing and documenting a management plan that addresses the primary problem, all co-morbidities, as well as cost considerations Understands the rationale for, risks, benefits and costs of different therapies used in the management of these diseases. Develops an appropriate treatment plan for the care of a patient with a rheumatologic problem integrating medications (oral, injectable, infused), other therapies when appropriate (counseling, physical therapy referral, occupational therapy referral) and when necessary other consultation. Demonstrates the ability to explain the rationale and the risks/benefits for the treatment plan and engage patients and parents in shared decision making. Knows the clinical pharmacology of each medication: understands the dosing, pharmacokinetics, metabolism, mechanisms of action, side effects, drug interactions, compliance issues, costs, and use in patients of child-bearing potential. Explains the indications for and performs arthrocentesis. Recognizes and manages ocular manifestations and complications of rheumatologic and musculoskeletal diseases in collaboration with ophthalmologists. Assesses and manage pain. Identifies physical impairment, relates the impairment to the observed functional deficits and prescribes appropriate physical therapy and occupational therapy to achieve goals to improve the defined impairment. Identifies and addresses barriers to adherence to treatment plan. Reassesses patients over time, recognizing treatment related adverse events, and alters the treatment plan accordingly. Determines the need for medication dose escalation, reduction, or withdrawal, or additional medication initiation. Identifies when referral to other specialists is indicated, for example: Nephrologist for lupus nephritis or vasculitis with glomerulonephritis. Ophthalmologist for juvenile idiopathic arthritis or others at risk for ocular inflammation. Dermatologist for cutaneous manifestations of lupus, dermatomyositis, scleroderma, or vasculitis. Hematologist for blood dyscrasias Cardiologist for myocarditis and/or pericarditis Collaborate and communicate effectively with other subspecialists and providers to co-manage patients receiving immunomodulatory therapy. Coordinating care in different health care settings (e.g. ER, hospital) and with an interdisciplinary health care team

Managing the acutely ill hospitalized patient with either a rheumatic disease or high suspicion for rheumatic disease. Initiates immunosuppressive therapy in the patient without a defined rheumatic disease if other diagnostic possibilities have been ruled out or when such therapy can reasonably be expected to not cause deterioration in patient clinical status. Co-manages with a general medical team if indication for hospitalization is not due to patient s primary rheumatic disease. Co-manages with critical care team in patients who require such care. Determines when patient can be safely discharged to home based on clinical status and patient/family ability to manage disease and treatment at home. Managing patients with acute or chronic complex rheumatic disease in the emergency setting. Assesses disease activity status through targeted history of present illness, physical exam, and laboratory and radiologic testing. Recognizes urgent/life threatening rheumatologic conditions such as: Macrophage activation syndrome Catastrophic antiphospholipid antibody syndrome (APA) Pulmonary embolus, pulmonary hemorrhage or myocardial Infarction in systemic lupus erythematosus Pericarditis associated with a rheumatic condition Cerebrovascular accident complicating a rheumatic condition Determines whether input from other subspecialists is required. Distinguishes disease flare from adverse treatment effect. Determines need for medication dose escalation, reduction, or withdrawal, or additional medication initiation. Assesses whether patient s current clinical status would improve with inpatient admission. Arranges post-visit follow up as needed. Placing the patient at the center of all management decisions Explains the management to patients and families. Invites questions from family. Includes family in shared decision-making. Communicates effectively with other members of the multidisciplinary team, consultants, and other providers. Demonstrating the ability to manage uncertainty (one s own as well as that of the patient and family) Consults with other experts in the field. Develops consensus with colleagues. Discusses inherent uncertainty in diagnosis with patient and referring physician. Frequently reassesses history, physical exam and laboratory data.

Problems generally within the scope of pediatric rheumatology practice (based on prevalence and potential morbidity) where the role of the rheumatologist is to recognize, evaluate and treat or determine that the patient needs referral to a different subspecialist for more specialized treatment. Juvenile Idiopathic Arthritis (all subtypes) Inflammatory Eye Disease Idiopathic Inflammatory Myositis Systemic Vasculitis (Henoch-Scholein Purpura, Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, Polyarteritis nodosa, Kawasaki disease, Takayasu arteritis, Behçet disease, central nervous system vasculitis) Systemic Lupus Erythematosus and Related Disorders Scleroderma, local and systemic and Related Disorders Autoinflammatory diseases Primary immunodeficiencies and other disorders associated with inflammatory and autoimmune manifestations Arthritis related to infection and associated conditions. Non-inflammatory musculoskeletal conditions Problems that generally require further consultation where the role of the subspecialist is to recognize, provide preliminary evaluation, and refer/co-manage. Nephrologist for lupus nephritis or vasculitis with glomerulonephritis Ophthalmologist for juvenile idiopathic arthritis or others at risk for ocular inflammation Dermatologist for cutaneous manifestations of lupus, dermatomyositis, scleroderma, or vasculitis. Hematologist for blood dyscrasias Cardiologist for myocarditis and/or pericarditis (Collaboration and communication with other subspecialists and providers to comanage patients receiving immunomodulatory therapy is critical.)